Quantcast

Novartis’ eye care division Alcon buys US-based private mdical device company for $285M

Novartis’ eye care division Alcon has bought a privately-held US medical device company PowerVision, which focuses on focused on creating fluid-based intraocular lens implants, for $285 million at closing with additional payments based on specified regulatory and commercial milestones starting in 2023.

Read more